Singapore markets closed
Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,070.55 +59.95 (+1.20%) Dow
38,503.69 +263.71 (+0.69%) Nasdaq
15,696.64 +245.33 (+1.59%) Bitcoin USD
66,417.59 +206.30 (+0.31%) CMC Crypto 200
1,434.94 +10.84 (+0.76%)
GILD Jan 2025 85.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:57PM EDT. Market open.
| Previous close | 1.0000 |
| Open | 0.9900 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 85.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.9900 - 1.0100 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.61k |
ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksGilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
ZacksInsights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Gilead (GILD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
© 2024 Yahoo. All rights reserved.